| Magenetec, India for LED operating Lights and Operating Tables |
| The Colonair Procedure |
Cyclical Colonic Stimulation (CCS) is a procedure that can be performed using the Colonair Device. It involves the use of a rectal probe to stimulate the colonic musculature. The procedure requires 5-10 minutes to perform, and is minimally invasive as the rectal probe is only inserted one inch into the rectum. CCS is performed without the use of anesthesia or sedation.
The Colonair procedure is well tolerated as patients can return to normal activities immediately following the procedure. Relief of IBS symptoms does not normally begin until 12-24 hours following the procedure. To date there has been no significant side effects and no complications resulting from the use of the Colonair device.
The mechanism of action of the Colonair procedure is not fully understood. The role of the placebo effect has not been ruled out in Cyclical Colonic Stimulation. It is hoped that with wider involvement of the academic Gastroenterology community, more light will be shed on the true effectiveness, safety and mechanism of action of Cyclical Colonic Stimulation. |
| Advantages of Colonair |
| The Colonair device was designed to maximize safety and efficacy. Since the Colonair procedure(CCS) is intended for outpatient use, patient comfort was given priority. These are some of the unique features of treating IBS-C using the Colonair device/Cyclical Colonic Stimulation: |
| |
|
 |
Causes minimum to no discomfort during and after treatment. |
|
Requires 5-10 minutes in an outpatient setting without sedation or anesthesia |
|
It is minimally invasive; probe is inserted one inch past the rectal sphincter. |
|
Designed to provide sustained relief of IBS symptoms. |
|
May be used in conjunction with other IBS treatment modalities. |
|
To date, there have been no significant side effects resulting from the treatment. |
|
To date, there have been no complications resulting from the treatment. |
|
| Clinical Trials |
Cyclical Colonic Stimulation has been subject to clinical testing since 2005. An early safety study was conducted in 2005-2006. Preliminary results from another safety and efficacy FDA clinical trial (2008-2009) demonstrated efficacy in subjects with IBS-Constipation. There were no adverse effects or complications resulting from the use of the Colonair device in both trials. In the most recent study, treatment was shown to cause relief of IBS-C symptoms along with global improvement in quality of life. Abstract with early results was submitted in 2008 for posting at the Canadian Digestive Disease Weekly-2009
www.pulsus.com/cddw2009/abs/249.htm
Much work needs to be done, as early findings with the Colonair technology must be verified in wider studies. Plans are under way for expanded studies in both the USA and Canada. Gastroenterologists are invited to participate as investigators in future trials to study the safety and efficacy of Colonair/CCS in patients with IBS-constipation.
Visit: www.colonair.com |
| |
|
|
| Our Objectives |
To assist non profit agencies obtain outside funding for the development and implementation of innovative and necessary programs and projects for at-risk and special population groups.
The intent is to improve the quality of life, for those who are facing challenges, those who have |
| read more |
|
|
Companies Represented
|
 |
Meditherm, USA Thermal imaging systems |
|
SCALENE, India |
|
Mediflex, USA Surgical and Laparoscopic quipments |
|
Cymo, the Netherlands for videokymography
systems |
|
PEAK surgical, USA for Plasma surgery |
|
HAB Herrmann, Germany for Ozone and Colon Hydrotherapy |
|
Colonair, USA for IBS syndrome |
|
Magenetec, India for LED operating Lights and Operating Tables |
|
MIGUN, KOREA, for acupunture, acupressure, FIR beds, |
|
SIMED INTERNATIONAL, The Netherlands for turn key Hospital project consultancy |
|
KGD India |
|
|
|
|
